ScreenerHero
LHLabcorp Holdings Inc.
NYSE · US · Healthcare · Diagnostics & Research · labcorp.com
332.15USD+0.52%Mkt Cap: 26.80B $P/E: 27.35

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, bloo…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap26.80B $
Enterprise Value33.69B $
Revenue (TTM)14.35B $
Gross Profit4.01B $
Net Income (TTM)876.50M $
Revenue/Share174.02 USD
Last Price332.15 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees71.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)27.35
P/E (Forward)16.82
PEG1.38
EV/EBITDA14.52
EV/Revenue2.35
P/S1.88
P/B3.13
EPS (TTM)12.18
EPS (Forward)19.78
52W Range
244.52100% of range331.20
52W High331.20 USD
52W Low244.52 USD
Profitability
Gross Margin28.76%
Oper. Margin12.24%
EBITDA Margin16.17%
Profit Margin6.28%
ROE10.17%
ROA4.77%
Growth
Revenue Growth5.80%
Earnings Growth28.20%
Cash Flow & Leverage
Operating CF1.64B $
CapEx (TTM)434.50M $
FCF Margin6.22%
FCF Yield3.33%
Net Debt6.68B $
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity0.76
Current Ratio1.80
Quick Ratio1.25
Book Value/Sh106.39 USD
Cash/Share1.748 USD
Dividends
Fwd Div Rate2.880 USD
Trail. Div Rate2.880 USD
Div. Yield0.87%
5Y Avg Yield—
Payout Ratio23.82%
Ex-Div DateAug 28, 2026
Pay DateSep 11, 2026
Splits
Last Split1164:1000
Split DateJul 3, 2023
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)337.75 USD
Upside (mean)+1.7%
Target Range270.00 USD – 385.00 USD
$270.00+1.7% to mean$385.00
# Analysts16
Ownership
Shares Out.81.10M
Float80.71M
Insiders0.35%
Institutions102.41%
Short Interest
Short Ratio2.7d
Short % Float2.60%
Short % Out.2.59%
Shares Short2.09M
Short (prev mo.)2.83M
Technical
SMA 50290.91 (+14.2%)
SMA 200271.48 (+22.4%)
Beta0.84
S&P 52W Chg18.16%
Avg Vol (30d)551.34K
Avg Vol (10d)526.06K
Technical Indicators
RSI (14)72.7
MACD10.7049
MACD Signal10.7767
MACD Hist.-0.0718
BB Upper334.24 USD
BB Middle314.42 USD
BB Lower294.59 USD
BB Width12.61%
ATR (14)7.768 USD
Vol Ratio (20d)0.67x